Surgery, Gastroenterology and Oncology
Vol. 26, Nr. 3, Sept 2021
Early Experience with Minimally Invasive Surgery for Complications of Pancreatitis
Yun Le Linn, Zhongkai Wang, Brian K. P. Goh
ORIGINAL PAPER, Sept 2021
Article DOI: 10.21614/sgo-26-3-344
Introduction: Surgical management is usually reserved as the last resort treatment for complications of pancreatitis. These have traditionally been performed via open surgery due to the dense adhesions resulting from the surrounding tissue inflammation from pancreatitis. However, with recent advancements in minimally-invasive pancreatic surgery, increasing numbers of studies have reported the safety and feasibility of performing these procedures via laparoscopic or robotic-assisted surgery. In this study, we present our initial experience with 7 consecutive cases of minimally invasive pancreatic surgery (MIPS) performed for the management of pancreatitis. Method: Retrospective review of 7 consecutive patients who underwent MIPS for pancreatitis between 2016-2020.

Results: There were 2 laparoscopic necrosectomies with distal pancreaticosplenectomies for ruptured pseudocysts, 1 laparoscopic ligation of pancreaticopleural fistula, 1 laparoscopic cyst-jejunostomy for pseudocyst, 1 laparoscopic cyst-gastrostomy for pseudocyst, 1 robotic modified Puestow procedure for chronic pancreatitis and one robotic-assisted distal pancreaticosplenectomy and drainage of necrosis for walled off necrosis. The overall, median operative time was 290 (range, 65-490) min, median blood loss was 50 (range, 0-1200) ml and median length of stay was 7 (range, 4-32) days. There were 2 grade 3 complications due to postoperative pancreatic fistulae.

Conclusion: This early experience demonstrated that MIPS is a safe and feasible alternative to open surgery for the treatment of complications of pancreatitis.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 211


Video Abstracts


Open Access Fee

Members of the IASGO will not pay open access fee. Non-members of IASGO will pay publishing fee of €150. Publishing fee, which will cover the DOI, plagiarism check, the editing work.


Journal Subscriptions

Current Issue

Sept 2021

Supplements

Instructions for authors
Online submission
Contact
Print ISSN: 2559 - 723X

ISSN-L: 2559 - 723X

ISSN online: 2601 - 1700

Surgery, Gastroenterology and Oncology is indexed in Scopus, CrossRef (DOI: 10.21614/sgo)



Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.